Filing Details
- Accession Number:
- 0000899243-22-001806
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-01-12 19:25:48
- Reporting Period:
- 2022-01-10
- Accepted Time:
- 2022-01-12 19:25:48
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1835579 | Ikena Oncology Inc. | IKNA | Biological Products, (No Disgnostic Substances) (2836) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1895321 | Michelle Xiaoyan Zhang | C/O Ikena Oncology, Inc. 645 Summer Street, Suite 101 Boston MA 02210 | Chief Scientific Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-01-10 | 36 | $2.15 | 44,511 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2022-01-10 | 36 | $12.00 | 44,475 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2022-01-11 | 964 | $2.15 | 45,439 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2022-01-11 | 964 | $12.00 | 44,475 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2022-01-10 | 36 | $0.00 | 36 | $2.15 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2022-01-11 | 964 | $0.00 | 964 | $2.15 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 25,437 | 2028-12-17 | No | 4 | M | Direct | |
| 24,473 | 2028-12-17 | No | 4 | M | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 22, 2021.
- 25% of the shares subject to this option vested and became exercisable on December 14, 2018, with the remainder vesting in 36 substantially equal monthly installments thereafter.
Billionaire Hedge Funds
